Symbiotec Pharmalab IPO Receives 1.85 Times Subscription
· Business · Business Standard, Economic Times, LiveMint
The initial public offering of Symbiotec Pharmalab has been subscribed 1.85 times as of the latest data. The company is seeking to raise capital through this public issue, though the specific financial targets were not disclosed in the report. Investors have placed bids for a total of 1.85 times the shares on offer. The subscription process remains ongoing, and the final tally will be determined at the close of the issue.
Why it matters
The subscription level serves as a key indicator of investor appetite for the company's shares ahead of its stock market listing.
Read the original report — Business Standard
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.